BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kayal M, Shah S. Ulcerative Colitis: Current and Emerging Treatment Strategies. J Clin Med 2019;9:E94. [PMID: 31905945 DOI: 10.3390/jcm9010094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Debnath N, Kumar R, Kumar A, Mehta PK, Yadav AK. Gut-microbiota derived bioactive metabolites and their functions in host physiology. Biotechnol Genet Eng Rev 2021;37:105-53. [PMID: 34678130 DOI: 10.1080/02648725.2021.1989847] [Reference Citation Analysis]
2 Omayone TP, Olaleye SB. Biochemical and histopathological effects of low dose vanadium in the healing of acetic acid-induced colitis in male wistar rats. J Basic Clin Physiol Pharmacol 2021. [PMID: 33592685 DOI: 10.1515/jbcpp-2020-0246] [Reference Citation Analysis]
3 Liu B, Zheng X, Li J, Li X, Wu R, Yang J, Liu W, Zhao G. Revealing mechanism of Caulis Sargentodoxae for the treatment of ulcerative colitis based on network pharmacology approach. Biosci Rep 2021;41:BSR20204005. [PMID: 33432986 DOI: 10.1042/BSR20204005] [Reference Citation Analysis]
4 Duan R, Wu Y, Wang M, Wu J, Wang X, Wang Z, Hu Y, Duan L. Association between short-term exposure to fine particulate pollution and outpatient visits for ulcerative colitis in Beijing, China: A time-series study. Ecotoxicol Environ Saf 2021;214:112116. [PMID: 33706140 DOI: 10.1016/j.ecoenv.2021.112116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Singh A, Mandal UK, Narang RK. Development and In Vivo Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and Saccharomyces boulardii for Management of Ulcerative Colitis. Assay Drug Dev Technol 2021. [PMID: 34780287 DOI: 10.1089/adt.2021.052] [Reference Citation Analysis]
6 Olbei M, Thomas JP, Hautefort I, Treveil A, Bohar B, Madgwick M, Gul L, Csabai L, Modos D, Korcsmaros T. CytokineLink: A Cytokine Communication Map to Analyse Immune Responses-Case Studies in Inflammatory Bowel Disease and COVID-19. Cells 2021;10:2242. [PMID: 34571891 DOI: 10.3390/cells10092242] [Reference Citation Analysis]
7 Sun Z, Li J, Dai Y, Wang W, Shi R, Wang Z, Ding P, Lu Q, Jiang H, Pei W, Zhao X, Guo Y, Liu J, Tan X, Mao T. Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota. Front Microbiol 2020;11:731. [PMID: 32425906 DOI: 10.3389/fmicb.2020.00731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
8 Li C, Wang J, Ma R, Li L, Wu W, Cai D, Lu Q. Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis. Pharmacol Res 2021;175:105972. [PMID: 34758401 DOI: 10.1016/j.phrs.2021.105972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wu MM, Wang QM, Huang BY, Mai CT, Wang CL, Wang TT, Zhang XJ. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharmacol Res 2021;172:105796. [PMID: 34343656 DOI: 10.1016/j.phrs.2021.105796] [Reference Citation Analysis]
10 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel) 2021;14:341. [PMID: 33917884 DOI: 10.3390/ph14040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wei Y, Jiang N, Liu T, Liu C, Xiao W, Liang L, Li T, Yu Y. The comparison of extraction methods of ganjiang decoction based on fingerprint, quantitative analysis and pharmacodynamics. Chin Med 2020;15:81. [PMID: 32774446 DOI: 10.1186/s13020-020-00355-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen K, Lou Y, Zhu Y. Tong Xie Yao Fang: A Classic Chinese Medicine Prescription with Potential for the Treatment of Ulcerative Colitis. Evid Based Complement Alternat Med 2021;2021:5548764. [PMID: 34211567 DOI: 10.1155/2021/5548764] [Reference Citation Analysis]
14 Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML, Olivero A, Armandi A, Vanni E, Younes R, Fagoonee S, Pellicano R, Astegiano M, Saracco GM, Bugianesi E, Ribaldone DG. On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. J Clin Med 2020;9:E800. [PMID: 32183476 DOI: 10.3390/jcm9030800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
15 Franco FCZ, Oliveira MCCD, Gaburri PD, Franco DCZ, Chebli JMF. HIGH PREVALENCE OF NON-ADHERENCE TO ULCERATIVE COLITIS THERAPY IN REMISSION: KNOWING THE PROBLEM TO PREVENT LOSS. Arq Gastroenterol 2022;59:40-6. [DOI: 10.1590/s0004-2803.202200001-08] [Reference Citation Analysis]
16 Kassab RB, Elbaz M, Oyouni AAA, Mufti AH, Theyab A, Al-Brakati A, Mohamed HA, Hebishy AMS, Elmallah MIY, Abdelfattah MS, Abdel Moneim AE. Anticolitic activity of prodigiosin loaded with selenium nanoparticles on acetic acid-induced colitis in rats. Environ Sci Pollut Res Int 2022. [PMID: 35320477 DOI: 10.1007/s11356-022-19747-1] [Reference Citation Analysis]